Skip to Main Content

Paper Details

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.
Science
327
2015
-deficient dendritic cells, FPR1, Fpr1, Fpr1(-/-), Fpr1-deficient dendritic cells, annexin-1, anthracycline, anthracyclines, breast and colorectal cancer, cancer, dying cancer, dying cancer cells, formyl peptide, formyl peptide receptor 1, human, human or murine leukocytes, intratumoral, intratumoral dendritic cells, mice, murine, patients, tumor
Author NameAffiliation
Celine LefebvreFrance. INSERM
Pierre Laurent-PuigUniversite Paris Sorbonne Cite, INSERM, France. INSERM U1147
  • 1 - 2

Datasets

Release 1.2